港股異動丨鴻騰精密大升超19% 機構指其淨利潤表現符預期 看好盈利前景
鴻騰精密(6088.HK)逆勢大幅拉昇升超19%,股價重回3港元大關,總市值224.5億港元。消息上,公司昨日盤後公吿,前三季持續經營之淨利潤同比增長約1.18倍,其中Q3來自持續經營之淨利潤6800.5萬元,同比增23.86%。招銀國際點評稱,公司淨利潤表現符預期,展望4Q24和FY25,該行認為英偉達GB200AI服務器業務放量、汽車電子Auto-Kabel集團收購併表以及大客户聲學產品在印度產線擴張的進展,都將促進公司收入和淨利潤的持續增長。重申鴻騰精密“買入”評級,看好其盈利前景。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.